NCT01384058
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Brain Damage, Chronic, +21 more
- Locations
-
- Institut für Stoffwechselforschung Frankfurt, Germany
- Stephan Jacob, MD Villingen-Schwenningen, Germany
Clinical trial condition
Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.
NCT01384058
NCT00637078
NCT01614561
Not specified
NCT00945737
NCT01222182
NCT01604733
Not specified
NCT00826774
Not specified
NCT00860509
NCT00000594
Not specified
NCT00860054